Advertisement
Research Article

Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal

  • Elena Losina mail,

    elosina@partners.org

    Affiliations: Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America

    X
  • Hapsatou Touré,

    Affiliation: INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France

    X
  • Lauren M. Uhler,

    Affiliation: Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America

    X
  • Xavier Anglaret,

    Affiliations: INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France, Centre de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire

    X
  • A. David Paltiel,

    Affiliation: Yale University, New Haven, Connecticut, United States of America

    X
  • Eric Balestre,

    Affiliation: INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France

    X
  • Rochelle P. Walensky,

    Affiliations: Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America, Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Center for AIDS Research, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Eugène Messou,

    Affiliation: Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Milton C. Weinstein,

    Affiliation: Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • François Dabis,

    Affiliation: INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France

    X
  • Kenneth A. Freedberg,

    Affiliations: Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America, Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Center for AIDS Research, Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America

    X
  • for the ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA),
  • and the CEPAC International investigators
  • Published: October 27, 2009
  • DOI: 10.1371/journal.pmed.1000173

Reader Comments (0)

Post a new comment on this article